Increased <scp>PD</scp>‐1/<scp>PD</scp>‐<scp>L1</scp> Immune Checkpoint Expression Is Associated With Oral Squamous Cell Carcinoma in Never‐Smokers and Never‐Drinkers
OSCC arising in never-smokers/never-drinkers exhibit heightened PD-1/PD-L1 signaling, suggesting potential efficacy of immune checkpoint therapy in this subgroup of tumors.
Authors
- Mathias Fiedler (ORCID: https://orcid.org/0000-0002-6822-3089)
- Tobias Ettl (ORCID: https://orcid.org/0000-0002-0549-5351)
- Michael Maurer (ORCID: https://orcid.org/0000-0003-0905-178X)
- Torsten E. Reichert
- Florian Weber (ORCID: https://orcid.org/0000-0001-7480-8828)
- Michael Gerken (ORCID: https://orcid.org/0000-0001-8610-9303)
- Maximilian Gottsauner (ORCID: https://orcid.org/0000-0003-3623-3183)
- Annette Gärtner (ORCID: https://orcid.org/0000-0001-6189-9679)
- Gero Brockhoff (ORCID: https://orcid.org/0000-0001-8398-8349)
- Jonas Eichberger
- Johannes G. Schuderer (ORCID: https://orcid.org/0000-0002-3973-2474)
- Alisa Off
- Richard J. Bauer
Institutions
- University Hospital Regensburg (DE)
- Caritas-Krankenhaus St. Josef (DE)
- University of Regensburg (DE)
Publication Details
- Journal
- Head & Neck
- Published
- 2024-10-27
- DOI
- https://doi.org/10.1002/hed.27981
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Universität Regensburg